We have a proven track record in fostering industry partnerships to deliver population health improvements, from start-ups to global players. The benefits of devolution, combined with the strength of our commercial life sciences sector and assets in health tech, data analysis and healthcare put us in a fantastic position to accelerate innovation that will improve health outcomes for our citizens.